Skip To Main Content
Zeeshan Khan on Muck Rack

Zeeshan Khan

As seen in: Sportskeeda, Dailymotion, Illumination, Medium, MSN, MSN Canada, MSN Money Canada, arXiv, PLOS ONE, MDPI, Flipboard and

Get in touch with Zeeshan

Contact Zeeshan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Pharma Quality Standards

|
By Zeeshan Khan
| The Nation (Pakistan) Verified
Pakistan’s pharmaceutical industry has come a long way. With annual sales estimated at around $3 billion and hundreds of manufacturing licences, the sector has become an important pillar of the country’s healthcare system, industrial base and export potential. Yet, when measured against the world’s most demanding pharmaceutical markets, Pakistan still has a considerable distance to travel. The real question is no longer whether Pakistan can manufacture medicines. It clearly can.
Open in Who Shared Issue with article?

Book Review: MUHAMMAD (pbuh) The Merciful

|
By Zeeshan Khan
| HT Syndication
Srinagar, Aug. 21 -- Dr. Muhammad Tahir-ul-Qadri is not just a preacher but also a writer, appealing to both youth and elders with a taste for reading. He does not confine his ideas to Muslims alone, but presents his opinions in a way that is accessible to a wider audience. Years ago, my hands fell on the thick book with an elegant cover page, captivating title, and aesthetic paper.
Open in Who Shared Issue with article?

Торговые сигналы для MetaTrader 5: Shani Forex Trader

|
By Zeeshan Khan
| mql5.com
Подписка на сигналы с плечом более 1:500 не разрешена Подписка будет разрешена после начала торговли Счет История сделок Статистика Риски Проскальзывание Описание Отзывы Новости Авторизуйтесь или зарегистрируйтесь и получите доступ к текущим сделкам поставщика Средства Просадка Всего трейдов: 9 Прибыльных трейдов: 9 (100.00%) Убыточных трейдов: 0 (0.00%) Лучший трейд: 8.42 USD Худший трейд: 0.00 USD Общая прибыль: 31.95 USD (20 666 pips) Общий убыток: 0.00 USD Макс.
Open in Who Shared Issue with article?
See all 1,007 licensed articles (1,016 Total)